Zobrazeno 1 - 10
of 156
pro vyhledávání: ''
Autor:
Rohit Mehra, Emmanuel S. Antonarakis, Javed Siddiqui, Felix Y. Feng, Costantine Albany, Przemyslaw Twardowski, Bruce Montgomery, Yi-Mi Wu, Karen E. Knudsen, Maha Hussain, Young E. Whang, Mark N. Stein, Dan R. Robinson, Daniel H. Shevrin, Arul M. Chinnaiyan, Megan E.V. Caram, Lakshmi P. Kunju, Walter M. Stadler, Kathleen A. Cooney, Xuhong Cao, Stephanie Daignault-Newton, Robert J. Lonigro, Paul G. Corn, David Smith, Scott A. Tomlins
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 36, iss 10
Purpose To determine whether cotargeting poly (ADP-ribose) polymerase-1 plus androgen receptor is superior to androgen receptor inhibition in metastatic castration-resistant prostate cancer (mCRPC) and whether ETS fusions predict response. Patients a
Autor:
Peter Kamper, Alexander Lindholm d'Amore, David W. Scott, Joseph M. Connors, Randy D. Gascoyne, Marcel Nijland, Sohrab P. Shah, Christian Steidl, Anja Mottok, Anke van den Berg, Stephen Hamilton-Dutoit, Fong Chun Chan, Alina S. Gerrie, Kerry J. Savage, Maryse M. Power, Arjan Diepstra, Francesco d'Amore
Publikováno v:
Chan, F C, Mottok, A, Gerrie, A S, Power, M, Nijland, M, Diepstra, A, van den Berg, A, Kamper, P, d'Amore, F, d'Amore, A L, Hamilton-Dutoit, S, Savage, K J, Shah, S P, Connors, J M, Gascoyne, R D, Scott, D W & Steidl, C 2017, ' Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma ', Journal of Clinical Oncology, vol. 35, no. 32, pp. 3722-3733 . https://doi.org/10.1200/JCO.2017.72.7925
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35(32), 3722-3733. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35(32), 3722-3733. AMER SOC CLINICAL ONCOLOGY
Purpose Our aim was to capture the biology of classical Hodgkin lymphoma (cHL) at the time of relapse and discover novel and robust biomarkers that predict outcomes after autologous stem-cell transplantation (ASCT). Materials and Methods We performed
Autor:
James H. Doroshow, DW Visscher, Matthew P. Goetz, Stephanie L. Safgren, Vera J. Suman, Andrew T. Ralya, Michael A. Mahr, Tufia C. Haddad, James N. Ingle, Benjamin R. Kipp, Jerry M. Collins, Joel M. Reid, Charles Erlichman, Zachary R. Chalmers, Garrett M. Frampton, Alex A. Adjei, John R. Hawse, Don W. Northfelt, Travis J. Dockter, Minetta C. Liu, Mary J. Kuffel, Sarah A. Buhrow, Matthew M. Ames, John L. Black, Howard Streicher, Renee M. McGovern
Publikováno v:
Journal of Clinical Oncology. 35:3391-3400
Purpose Endoxifen is a tamoxifen metabolite with potent antiestrogenic activity. Patients and Methods We performed a phase I study of oral Z-endoxifen to determine its toxicities, maximum tolerated dose (MTD), pharmacokinetics, and clinical activity.
Autor:
Stephanie Harmon, Glenn Liu, William L. Dahut, Timothy Perk, Robert Jeraj, Christie Lin, Jens Eickhoff, Andrea B. Apolo, Steven M. Larson, John L. Humm, Peter L. Choyke, Michael J. Morris
Publikováno v:
Journal of Clinical Oncology. 35:2829-2837
Purpose [18F]Sodium fluoride (NaF) positron emission tomography (PET)/computed tomography (CT) is a promising radiotracer for quantitative assessment of bone metastases. This study assesses changes in early NaF PET/CT response measures in metastatic
Autor:
Charles A. Powell
Publikováno v:
Journal of Clinical Oncology. 35:705-708
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and
Autor:
Malene Hildebrandt, Kirsten Falch, Sandra Duvnjak, Inguna Buskevica, Jeanette Ansholm Hansen, Marianne Ewertz, Lisbet Brønsro Larsen, Selma Bektas, Ziba Ahangarani Farahani, Oke Gerke, Katrine Lydolph Søe, Anne Marie Bak Jylling, Christina Baun, Abass Alavi, Henrik Gordon Petersen, Poul Flemming Høilund-Carlsen
Publikováno v:
Journal of Clinical Oncology. 34:1889-1897
Purpose To prospectively investigate the diagnostic accuracy of [18F]fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) with dual-time-point imaging, contrast-enhanced CT (ceCT), and bone scintigraphy (BS) in patient
Autor:
Jeffrey E. Gershenwald, Charles R. Scoggins, Kelly M. McMasters, Peter D. Beitsch, B. Scott Davidson, Douglas S. Reintgen, Michael J. Edwards, Arnold J. Stromberg, James S. Goydos, Michael E. Egger, Marshall M. Urist, Stephan Ariyan, Jeffrey J. Sussman, Merrick I. Ross, Lee Hagendoorn, Robert C.G. Martin, R. Dirk Noyes
Publikováno v:
Journal of Clinical Oncology. 34:1079-1086
Purpose The Sunbelt Melanoma Trial is a prospective randomized trial evaluating the role of high-dose interferon alfa-2b therapy (HDI) or completion lymph node dissection (CLND) for patients with melanoma staged by sentinel lymph node (SLN) biopsy. P
Autor:
Vered Stearns
Publikováno v:
Journal of Clinical Oncology. 37:1986-1986
Publikováno v:
Journal of Clinical Oncology. 37:853-854
Autor:
Christoph Kimmich, Martin Granzow, Tilmann Bochtler, Hartmut Goldschmidt, U Hegenbart, Christina Kunz, Anna Jauch, Axel Benner, Stefan Schönland, Anja Seckinger, Dirk Hose, Anthony D. Ho
Publikováno v:
Journal of Clinical Oncology. 33:1371-1378
Purpose Bortezomib has become a cornerstone in the treatment of AL amyloidosis. In this study, we addressed the prognostic impact of cytogenetic aberrations for bortezomib-treated patients. Patients and Methods We analyzed a consecutive series of 101